Alkermes plc ALKS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Alkermes plc is an Ireland-based, fully integrated global biopharmaceutical company focused on developing and commercializing innovative medicines in neuroscience. It specializes in treatments for serious mental illnesses, addiction, schizophrenia, bipolar I disorder, alcohol and opioid dependence, and sleep disorders …
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryIreland
Employees2,050
TickerALKS
Statistics
Market Cap$7.46B
Revenue (TTM)$1.48B
Net Income$241.7M
Net Margin16.4%
EPS$1.43
P/E49.91
P/S4.79
P/B4.27
EV/EBITDA30.07
ROE9.4%
Dividend Yield—
Price$44.80
Data: Twelve Data · Revenue = mcap / P/S